Buza N
No ORCID on file
· 7 papers in corpus
· active 2010-2026
Study types
- review 1
Condition tags
- endometriosis 1
Top journals
Frequent coauthors
- Hui P 4
- Cocco E 3
- Azodi M 3
- Pecorelli S 3
- Alessandro D. Santin 3
- Schwartz PE 3
- Silasi DA 3
- Bellone S 3
- Lockwood CJ 2
- Malpica A 2
2026
review
2025
CONTEXT.—: Nearly a century has passed since a seminal review article was published in 1928 in Archives of Pathology on ectopic endometriosis, presenting the dominant pathogenetic theories of the era: the serosal theory suggesting that endo…
2022
ObjectiveTo examine clinicopathologic characteristics and oncologic outcomes of patients diagnosed with Mullerian adenosarcoma and to evaluate ovarian preservation as a practical management option in early-stage disease.MethodsA retrospecti…
2020
Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with b…
2018
Purpose: Uterine serous carcinoma (USC) is a rare and aggressive variant of endometrial cancer. Whole-exome sequencing (WES) studies have recently reported c-Myc gene amplification in a large number of USCs, suggesting c-Myc as a potential …
2011
We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease. We studied the expres…
2010
BackgroundUterine serous papillary adenocarcinoma (USPC) is a highly aggressive variant of endometrial cancer. Human immuno-conjugate molecule (hI-con1) is an antibody-like molecule targeted against tissue factor (TF), composed of two human…